Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered for primary immunisation in infants aged 2–12 months and as a booster in children aged 15 months to 6 years.

DTPa — diphtheria-tetanus-acellular pertussis combination vaccine

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • ≥30 IU diphtheria toxoid
  • ≥40 IU tetanus toxoid
  • 25 µg pertussis toxoid
  • 25 µg filamentous haemagglutinin
  • 8 µg pertactin

Adsorbed onto 0.5 mg aluminium as aluminium hydroxide.

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

DTPa
diphtheria-tetanus-acellular pertussis vaccine
IU
international units